TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Cognitive fatigue - Mindfulness Inventory for Sport
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Cognitive fatigue - Simon Task
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Cognitive fatigue - Pattern-comparison task
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Cognitive fatigue - Psychomotor task
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Physical fatigue - Shoulder endurance
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Physical fatigue - Handgrip test
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Physical fatigue - Isometric mid-thigh pull test
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in Mini Asthma Quality of Life Questionnaire Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in GERD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in GERD quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in GI symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prepartying frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drinks during prepartying
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed recAP plasma concentration (Cmax) after single dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to attain maximum recAP serum concentration (Tmax) after single dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration versus time curve (AUC) after single dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of stay (LoS)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Complication rate (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of Life assessment: Toronto Aortic Stenosis Quality of Life Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of participants with Grade 2 or lower hair loss
Endpoint domain: Adverse events/effects
Primary endpoint: Number of pain medications taken postoperatively
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Timing of pain medications taken postoperatively
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Body fat mass (in Kg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Body fat mass (in % of total body weight)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cure rate for tuberculosis infection
Endpoint domain: Mortality/survival
Primary endpoint: Ischemic Recurrences
Endpoint domain: Mortality/survival
Primary endpoint: cerebral haemodynamic effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean arterial pressure (MAP) targets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intracranial compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diaphragmatic thickening fraction (DTF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total concentration of the main MV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variation of the amplitude of rectal contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Facial appearance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Tissue oxygenation (TcO2) change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance in filling in the virtual case report form
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Oral Motor Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of the main metabolite 116-N1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t of the main metabolite 116-N1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-inf of the main metabolite 116-N1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of post-implantation syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: Ability to acquire gastrointestinal images in an unsedated infant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Ability for unsedated infant subjects to tolerate the device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to visualize gastrointestinal features in unsedated infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Survival rate of posterior occlusal multi-surface restorations
Endpoint domain: Mortality/survival
Primary endpoint: Achieving Disease Recovery by Day 5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in TMEPs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in MVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time profile (AUCinf/AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Durable response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of rilvegostomig discontinuation due to toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of ulcers with complete wound closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance with the telerehabilitation system
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Perceived usability of system
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Depth of corneal healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Participant Enrollment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of Participant Assessment Completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 2-year progression-free rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correction of spinal deformity (coronal)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Correction of spinal deformity (sagittal)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Area Under the Concentration-Time Curve from time zero to the time of the last observed/measured non-zero concentration (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-Time Curve from time 0 extrapolated to infinity (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Usability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Static balance index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of no major adverse events within 30 days after operation
Endpoint domain: Adverse events/effects
Primary endpoint: Success rate of treatment of abdominal aortic aneurysm 12 months after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pain post laparoscopic appendicectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Receiver Operating Characteristic curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of lipid composition in the breast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spatial distribution (skewness) of lipid composition in the breast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spatial distribution (entropy) of lipid composition in the breast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spatial distribution (kurtosis) of lipid composition in the breast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of post-surgical hematoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of time glucose value between 70 and 180 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Frequency of adherence to management guidelines
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in end-expiratory lung impedance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: rate of alignment inlier
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intervention usage - frequency
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intervention usage - duration
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: SANFL detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration time of the use of tourniquet
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Correctness of treatment of severe bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Duration time of the use of nasal airway
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Correctness of treatment of airway obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Duration time of the use of chest seal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: change in arsenic concentration in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Menstrual improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change From Baseline EQ-5D Health-Related Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change From Baseline Pain Disability Questionnaire (PDQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Patient Satisfaction and Understanding With HCHAPS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in the ratio of urine output to fluid input
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change of the levels of the patient-specific unbound furosemide fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-rated confidence for managing emergency situation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: performance in managing emergency situation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Concentration of netarsudil in the vitreous
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postpartum family planning adoption
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Motor Coordination Test (MCT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adaptation Test (ADT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Limits of Stability Test (LOS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uptake of STI testing
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: ICU Stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptomatic deep venous thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Prevalence of tongue anomalies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preliminary effectiveness: Sexual risk behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of positive pressure ventilation (PPV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of glaucoma-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Hospitalized patient rates
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Dropout rate in the FAST intervention group
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Longitudinal changes in body mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Longitudinal changes in fat-free mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Longitudinal changes in skeletal muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Longitudinal changes in total body water
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Longitudinal changes in extracellular water
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thermal comfort perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in mean blood pressures (mmHg) during intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Timed get-up-and-go score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Activation Model Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sleep Disturbance (subjective)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Percentage of obstructed catheters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of time BIS < 60
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of time PSI < 50
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of mesh infection
Endpoint domain: Adverse events/effects
Primary endpoint: rate of target lesion failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Fugl- Meyer Assessment (Upper Extremity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spatial speech in Noise - Virtual Acoustics (SSiN-VA) test outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Epworth Sleepiness Scale (ESS) Total Score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Urinary NNAL Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Western-Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3 Meter Backward Walk Test (3MBWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: One Leg Standing Test (OLST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Five Times Sit to Stand Test (5TSST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with dose modifications
Endpoint domain: Adverse events/effects
Primary endpoint: Margin of stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Development of cognitive dysfunction
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of Participants Achieving Responder Status Using ACSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving Responder Status Using AFLS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health Related Quality of Life (EQ-5D-5L)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Health Related Quality of Life (KBILD)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Dysplasia Detection Sensitivity and Specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: response to physical therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rebleeding risk within 30 days after discharge
Endpoint domain: Adverse events/effects
Primary endpoint: Solicited local and systemic adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: All Adverse Events related to injection
Endpoint domain: Adverse events/effects
Primary endpoint: Level of neutralizing antibody against SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of patients with a score of <30 on the Bowel Function Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean change in PCWP from baseline at 20W exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of therapy-related clonal hematopoiesis (t-CH) for patients with cardiovascular disease (CVD) after Hodgkin Lymphoma therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Objective signs of CVD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Heart Failure Knowledge Score Improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Patient preference for heart failure education module
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: INF-γ production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline lymphedema volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of expanded disability status scale (EDSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: standardized uptake value ratio (SUVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aβ42 in CSF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MMSE (Mini-mental State Examination)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Electroencephalographic functional connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in ISTH DIC Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fMRI markers for suicide risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: postoperative trismus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of H4 deep dTMS coils
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Tolerability of H4 deep dTMS coils
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of H4 deep dTMS coils
Endpoint domain: Adverse events/effects
Primary endpoint: Change of Insomnia Severity
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Knowledge and practice score on infant oral health care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Correlation analysis of race-based traumatic stress and allostatic load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incomplete blood count recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: SARS-CoV-2 Seroconversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Influenza Seroconversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Relative Muscle Oxygenation Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Hemoglobin Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of phototoxicity reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of esophageal stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: AUC0-672h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Survival in FGFR2b ≥ 10% 2+/3+ Tumor Cell Staining Participants
Endpoint domain: Mortality/survival
Primary endpoint: Radiographic measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic yield of BF-UC290F
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-occlusive hyperaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of SPPB Score from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of WOMAC 3.1 index from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Calories burned in planned exercise session
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Antiretroviral Therapy (ART) Initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes